Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This study aims at evaluating the therapeutic effects of both Nitazoxanide and Escitalopram
as adjuvant therapies in patients with Rheumatoid Arthritis and to evaluate their impact on
STAT3/ JAK2, TLR /IL -1β signaling pathways.